No registrations found.
ID
Source
Brief title
Health condition
medically unexplained physical symptoms (MUPS), undifferentiated somatoform disorder (USD)
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary clinical outcome is the development in physical functioning along the total follow-up period as measured by the physical component summary (PCS) of the RAND-36.
The primary outcome measure for the economic evaluation is quality of life as measured by the EuroQol/EQ-5D. Direct and indirect costs will be assessed with the TIC-P 20 and data on health care use extracted from the electronic medical records of the GPs. Direct costs will be based on the Dutch standard cost prices and the indirect costs will be estimated based on the average of the population.
Secondary outcome
Secondary outcome measures are the severity of somatisation (PHQ-15) and
depressive/anxiety symptoms (HADS).
Background summary
Cognitive-behavioural (CB) interventions decrease undifferentiated somatoform disorder (USD) symptoms and improve functioning in secondary care. To date it is, however, unknown whether a short-term CB intervention for USD, provided by a primary care mental health care practitioner (MHNP) is (cost-)effective compared to usual care.
In a cluster randomised controlled trial, with randomisation on MHNP level, 212 adult USD patients will be assigned to either the intervention or control group. The intervention group will be offered a short-term CB intervention in addition to usual GP care. The treatment rationale is the consequences model focusing on the consequences or problems that arise due to the USD. In 6 sessions patients will receive psycho-education, problem solving techniques, activity scheduling and relaxation techniques, to learn to cope with identified problems. The control group will receive usual GP care. The intervention aims to enhance physical (role) functioning as measured by the physical component summary of the RAND-36. An economic evaluation will also be conducted with quality of life as a primary outcome measure, assessed by the EQ-5D. Direct and indirect costs will be assessed with the TIC-P. Secondary outcomes include somatisation (PHQ-15) and symptoms of depression and anxiety (HADS). Assessments will be taken at 0, 2, 4 and 12 months.
Recruitment started in August 2015 and was completed March 2017. Follow-up measurements were completed in April 2018.
For main results see PubMed: PMID: 31285038
Study objective
We expect that the intervention will improve physical functioning, will be more cost-effective, and will reduce somatisation, depression and anxiety symptoms.
Study design
0, 2, 4 and 12 months after baseline
Intervention
Mental health nurse practitioners (MHNP) will offer intervention patients a short structured intervention based on cognitive-behavioural (CB) principles, in addition to usual GP care, to teach participants how to cope with the consequences of their symptoms. In up to 6 sessions patients will be provided with psycho-education, problem solving techniques, relaxation techniques, and activity scheduling. The consequences model of somatoform complaints has successfully been used in previous Dutch intervention studies and focuses on the consequences or problems that arise due to somatoform complaints and on their aggravating effects, rather than on causes of somatoform complaints. This model will be used as the treatment rationale. The focus is not so much on treating the symptoms, but rather on producing beneficial changes in (physical) functional outcome and quality of life. The MHNPs provide the CB approach of problem solving treatment (PST) as a means to learn to tackle and cope with the identified consequences. PST teaches problem-solving styles and skills. Several steps to problem solving have been described which will be practised during the sessions: 1) explanation of treatment rationale and ‘contracting’, 2) identification and clarification of problems, 3) the setting of clear goals, 4) formulation of alternative solutions, 5) selection of preferred solutions, 6) clarification of the necessary steps to implement solutions, and 7) evaluation of progress. In addition, activity scheduling and progressive relaxation techniques will be provided as these are important general features of CBT for somatoform complaints.
Patients in the control group will not be offered a specific additional intervention other than the care they would usually receive from the GP.
Hans van der Wouden
Medical Faculty, G-510
Department of General Practice & Elderly Care Medicine
VU University Medical Center
Van der Boechorststraat 7
Amsterdam 1081BT
The Netherlands
+31204448167
j.vanderwouden@amsterdamumc.nl
Hans van der Wouden
Medical Faculty, G-510
Department of General Practice & Elderly Care Medicine
VU University Medical Center
Van der Boechorststraat 7
Amsterdam 1081BT
The Netherlands
+31204448167
j.vanderwouden@amsterdamumc.nl
Inclusion criteria
1) Being 18 years of age or older
2) Meeting the criteria for undifferentiated somatoform disorder according to DSM IV:
a) The presence of 1 or more medically unexplained physical symptoms
b) The symptoms last at least 6 months
c) The symptoms significantly impair functioning/quality of life
Exclusion criteria
1) Having a medical disorder that explains the symptoms
2) Having a severe psychiatric disorder (i.e. psychosis-related disorders,
dementia and bipolar disorder)
3) Having a handicap such as cognitive mental impairment and/or blindness
4) Being unable to speak or read Dutch
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL4543 |
NTR-old | NTR4686 |
Other | ZonMw Programma Doelmatigheid : ZonMw dossier number 80-83700-98-42070 |
Summary results
Main results: Sitnikova K, Leone SS, van Marwijk HWJ, Twisk J, van der Horst HE, van der Wouden JC. Effectiveness of a cognitive behavioural intervention for patients
with undifferentiated somatoform disorder: Results from the CIPRUS cluster randomized controlled trial in primary care. J Psychosom Res. 2019 Jun 24:109745.
Economic evaluation: Forthcoming.